Market Overview:
The global trigeminal neuralgia treatment market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The drug-based segment is expected to dominate the market in terms of revenue share, owing to high adoption rates for drugs such as carbamazepine and gabapentin. However, the surgery-based segment is projected to grow at a higher CAGR during the forecast period.
Product Definition:
The term trigeminal neuralgia treatment refers to the various methods used to relieve the pain associated with trigeminal neuralgia, a condition that affects the trigeminal nerve. Trigeminal neuralgia is caused by damage to or compression of the trigeminal nerve, which can result in episodes of severe pain in one or more areas of the face.
There are a number of different treatments available for trigeminal neuralgia, including medications, surgery, and other therapies. The type of treatment chosen will depend on the severity of symptoms and on individual factors such as age and health history.
Drug Based:
Drug Based treatment for Trigeminal Neuralgia (TN) is expected to witness significant growth over the forecast period owing to increasing prevalence of the disease and lack of curative therapies. The drug based treatment includes anticonvulsants, antidepressants, local anesthetics and benzodiazepines as well as other drugs used in combination with these medications. These are some of the most commonly used medications for treating neuralgia caused by CNB1 receptor antagonist deficiency.
Surgery:
Surgery and it's usage in Trigeminal Neuralgia (TN) treatment market is a study analyzing the current medical practice related to surgery and its usage for treating trigeminal neuralgia. The trigeminal neuralgia is a chronic pain condition which affects one or both of the trigeminus nerve (cranial nerves V3-V4) that arise from the brainstem, pass through the skull and exit at their terminal branches into the face.
Application Insights:
Based on application, the global trigeminal neuralgia treatment market is segmented into hospitals, clinics and other medical facilities. Hospitals held the largest share of over 70.0% in 2017 owing to availability of advanced healthcare facilities along with a large number of patients suffering from TN that require surgeries for effective treatment. As per WHO, around 10-20% population across the globe suffers from this condition which requires surgery or medication for pain relief which contributes towards large patient base in hospitals for pain management resulting in high revenue generation therefor.
The clinic segment is expected to grow at fastest rate during forecast period due to growing awareness about treatments related to facial nerve compression syndrome among general practitioners and neurologists leading to increase in demand for such services resulting in higher revenue generation therefor as compared with hospital based settings.
Regional Analysis:
North America dominated the global market in 2017 owing to high awareness levels and availability of well-established healthcare facilities. Moreover, increasing prevalence of chronic conditions such as diabetes is also expected to boost the demand for neuralgia treatment in this region. For instance, according to a study published by CDC National Center for Health Statistics (NCHS), from 2015 to 2016 around 12.3 million adults in U.S had diabetes and another 7 million had risk factors that put them at higher risk for developing the disease.- see more at: //www.pwcglobalhealthcare.com/assets/pdf/zika-virus-impact-paper.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due its rapidly improving healthcare infrastructure coupled with rising patient awareness regarding advanced treatments available worldwide especially in developed economies such as North America and Europe.
Growth Factors:
- Increasing incidence of trigeminal neuralgia
- Growing awareness about trigeminal neuralgia and its treatment options
- Rising demand for minimally invasive procedures for trigeminal neuralgia treatment
- Technological advancements in the field of trigeminal neuralgia treatment
- Availability of affordable and accessible treatments for trigeminal neuralgia
Scope Of The Report
Report Attributes
Report Details
Report Title
Trigeminal Neuralgia Treatment Market Research Report
By Type
Drug Based, Surgery
By Application
Hospitals, Clinic, Others
By Companies
Allergan Plc, Biogen, Inc., Kineta Inc., Merz Pharma GmbH & Co., Trigemina Inc., Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc. , Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Trigeminal Neuralgia Treatment Market Report Segments:
The global Trigeminal Neuralgia Treatment market is segmented on the basis of:
Types
Drug Based, Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan Plc
- Biogen, Inc.
- Kineta Inc.
- Merz Pharma GmbH & Co.
- Trigemina Inc.
- Abbott Laboratories
- Pfizer Inc.
- GlaxoSmithKline Plc.
- Novartis
Highlights of The Trigeminal Neuralgia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Based
- Surgery
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Trigeminal Neuralgia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one definitive answer to this question as the best treatment for trigeminal neuralgia will vary depending on the individual's specific symptoms and medical history. However, some common treatments for trigeminal neuralgia include medication, surgery, and physical therapy.
Some of the key players operating in the trigeminal neuralgia treatment market are Allergan Plc, Biogen, Inc., Kineta Inc., Merz Pharma GmbH & Co., Trigemina Inc., Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc. , Novartis.
The trigeminal neuralgia treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Trigeminal Neuralgia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Trigeminal Neuralgia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Trigeminal Neuralgia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Trigeminal Neuralgia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Trigeminal Neuralgia Treatment Market Size & Forecast, 2018-2028
4.5.1 Trigeminal Neuralgia Treatment Market Size and Y-o-Y Growth
4.5.2 Trigeminal Neuralgia Treatment Market Absolute $ Opportunity
Chapter 5 Global Trigeminal Neuralgia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Trigeminal Neuralgia Treatment Market Size Forecast by Type
5.2.1 Drug Based
5.2.2 Surgery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Trigeminal Neuralgia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Trigeminal Neuralgia Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Trigeminal Neuralgia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Trigeminal Neuralgia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Trigeminal Neuralgia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Trigeminal Neuralgia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Trigeminal Neuralgia Treatment Market Size Forecast by Type
9.6.1 Drug Based
9.6.2 Surgery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Trigeminal Neuralgia Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Trigeminal Neuralgia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Trigeminal Neuralgia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Trigeminal Neuralgia Treatment Market Size Forecast by Type
10.6.1 Drug Based
10.6.2 Surgery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Trigeminal Neuralgia Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Trigeminal Neuralgia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Trigeminal Neuralgia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Trigeminal Neuralgia Treatment Market Size Forecast by Type
11.6.1 Drug Based
11.6.2 Surgery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Trigeminal Neuralgia Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Trigeminal Neuralgia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Trigeminal Neuralgia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Trigeminal Neuralgia Treatment Market Size Forecast by Type
12.6.1 Drug Based
12.6.2 Surgery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Trigeminal Neuralgia Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Trigeminal Neuralgia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Trigeminal Neuralgia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Trigeminal Neuralgia Treatment Market Size Forecast by Type
13.6.1 Drug Based
13.6.2 Surgery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Trigeminal Neuralgia Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Trigeminal Neuralgia Treatment Market: Competitive Dashboard
14.2 Global Trigeminal Neuralgia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan Plc
14.3.2 Biogen, Inc.
14.3.3 Kineta Inc.
14.3.4 Merz Pharma GmbH & Co.
14.3.5 Trigemina Inc.
14.3.6 Abbott Laboratories
14.3.7 Pfizer Inc.
14.3.8 GlaxoSmithKline Plc.
14.3.9 Novartis
